Side-by-side comparison of AI visibility scores, market position, and capabilities
Singapore Exchange-listed (SGX: C6L) premium international airline at SGD 19.54B revenue carrying 39.4M passengers; Temasek-owned with award-winning suites and Air India partnership competing with Emirates and Cathay Pacific.
Singapore Airlines is a Singapore-based premium international airline — listed on the Singapore Exchange (SGX: C6L) and majority-owned by Singapore's state investment company Temasek Holdings (~55% stake) — operating a global network connecting Singapore Changi Airport to 130+ destinations across 35 countries on six continents with a fleet of 220+ aircraft (A380, A350, B787, B737) known for award-winning service, premium cabin innovation, and operational excellence. Singapore Airlines generated SGD 19.54 billion ($14.5B USD) in revenue for fiscal year 2024-25 (+2.8% year-over-year), carried 39.4 million passengers (+8.1% growth), and reported a record net profit of SGD 2.8 billion — including a one-time SGD 1.1 billion gain from its partnership with Air India.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.